Professor Billy Wai-Lung Ng is an Assistant Professor at the School of Pharmacy at The Chinese University of Hong Kong (CUHK), where he leads the Laboratory of Chemical Biology & Drug Discovery. He has successfully used cutting-edge technologies to develop therapeutic molecules for combating viral pandemics and aging-related diseases. Professor Ng and his international team were the first to discover that an approved HCV drug can be repurposed for the treatment of COVID-19. He is currently creating disruptive therapeutic molecules with the ultimate goal to eradicate cancers and neurodegenerative diseases. Professor Ng completed his post-doctoral training at Harvard Medical School and the University of Oxford after receiving his Ph.D. and B.Sc. in Chemistry from CUHK. He was also a Fulbright Scholar at Massachusetts Institute of Technology (MIT) during his graduate study. He has received numerous prestigious awards, including the Marie Curie Fellowship, Croucher Foundation Postdoctoral Fellowship, and Hong Kong PhD Fellowship.

Mark Stoffels is a senior global health tech executive. As Global Business Unit Leader and Senior Vice-President of Royal Philips’ Image Guided Therapy Systems, he is highly driven to improve global access to healthcare. Other roles at Royal Philips include Managing Director and Senior Vice-President Connected Care North America, Vice-President and General of Latin America, Country Manager Mexico, General Manager Health Systems Mexico and Strategic Marketing Director for Latin America. Stoffels is the author of "3 Billion Heart Beats", a novel on Buddhism which principles he works tirelessly to implement in his leadership style.